UPDATE 2-Italy's Gentium plummets as EU says "no" to key drug

Shares in Italian biotech company Gentium plunged more than 40 percent after it failed to convince European regulators of the benefits of its most advanced drug candidate for a rare liver condition.

http://www.reuters.com/article/2013/02/21/gentium-europe-idUSL4N0BL4M020130221?feedType=RSS&feedName=governmentFilingsNews